Department of Bioengineering and Therapeutic Sciences

Giacomini co-led study finds gene variant affecting response to leading diabetes drug

Metformin is the most widely used initial medication for controlling blood sugar (glucose) in type 2 diabetes, a disease affecting 350 million people worldwide. The drug helps reduce their risk of complications leading to heart, eye, and kidney disease.

2016 Mentor of the Year: Francis Szoka

The American Foundation for Pharmaceutical Education(AFPE) announced Francis C. Szoka, PhD as the 2016 recipient of The Mentor of the Year Award. Szoka, professor in the UCSF School of Pharmacy Department of Bioengineering and Therapeutic Sciences, is the founder of Sequus Pharmaceuticals.

Weaver’s research featured in Cell Stem Cell

Research results from the lab of Valerie Weaver, PhD, were reported online July 21, 2016 in Cell Stem Cell.

30th annual course on Pharmacokinetics for Pharmaceutical Scientists

Pharmacokinetics for Pharmaceutical Scientists is an annual course, now in its 30th year.

Honoring Tsinghua Scholars

The Department of Bioengineering and Therapeutic Sciences (BTS) was pleased to present Certificates of Completion to Tsinghua University students who completed our Collaborative Education and Research Program.

Fulton receives Innovation in Education Award

The 2016 Dean’s Innovation in Education Award was presented to Tracy Fulton, PhD, on Thursday during the School of Pharmacy faculty meeting on the Parnassus campus.

Burchard leads call for diversity in research workforce

The photograph of Martin Luther King Jr. hanging on the wall of the Asthma Collaboratory lab in UC San Francisco’s Rock Hall serves a reminder to all who toil there, purifying DNA samples or analyzing genetic, social or environmental data that their research is also part of a dream of equality and...

Pages